168 related articles for article (PubMed ID: 27659535)
61. Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7.
Maher DM; Bell MC; O'Donnell EA; Gupta BK; Jaggi M; Chauhan SC
Mol Carcinog; 2011 Jan; 50(1):47-57. PubMed ID: 21061268
[TBL] [Abstract][Full Text] [Related]
62. Generation of the Fluorescent HPV16 E7 Protein for Detection of Delivery In vitro.
Shahbazi S; Bolhassani A; Arashkia A; Sadroddiny E
Protein Pept Lett; 2018; 25(3):244-252. PubMed ID: 29336241
[TBL] [Abstract][Full Text] [Related]
63. Immunohistochemical Detection of Human Papillomavirus 16 E7 Oncoprotein in Cervical Lesions.
Zhu J; Chen L; Zheng Q; Han R; Chen X; Zhou Q; Cheng H
J Cancer; 2021; 12(23):7130-7137. PubMed ID: 34729114
[TBL] [Abstract][Full Text] [Related]
64. Molecular Analysis of the Interaction between Human PTPN21 and the Oncoprotein E7 from Human Papillomavirus Genotype 18.
Lee HS; Kim MW; Jin KS; Shin HC; Kim WK; Lee SC; Kim SJ; Lee EW; Ku B
Mol Cells; 2021 Jan; 44(1):26-37. PubMed ID: 33431714
[TBL] [Abstract][Full Text] [Related]
65. Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors.
Miao Z; Ren G; Liu H; Jiang L; Cheng Z
J Biomed Opt; 2010; 15(3):036007. PubMed ID: 20615009
[TBL] [Abstract][Full Text] [Related]
66. Targeted biological effect of an affitoxin composed of an HPV16E7 affibody fused with granzyme B (ZHPV16E7-GrB) against cervical cancer in vitro and in vivo.
Wang W; Tan X; Jiang J; Cai Y; Feng F; Zhang L; Li W
Curr Cancer Drug Targets; 2020 Dec; ():. PubMed ID: 33292132
[TBL] [Abstract][Full Text] [Related]
67. Novel affibody molecules as potential agents in molecular imaging for MAGE-A3-positive tumor diagnosis.
Cai Y; Ren J; Jin J; Shao H; Wang P; Cheng K; Jiang P; Jiang P; Zhu S; Zhu G; Zhang L
Environ Res; 2023 Nov; 237(Pt 1):116895. PubMed ID: 37586454
[TBL] [Abstract][Full Text] [Related]
68. Structural investigation on the intrinsically disordered N-terminal region of HPV16 E7 protein.
Lee C; Kim DH; Lee SH; Su J; Han KH
BMB Rep; 2016 Aug; 49(8):431-6. PubMed ID: 27418281
[TBL] [Abstract][Full Text] [Related]
69. High-Risk Human Papillomavirus E7 Maintains Stemness Via APH1B In Cervical Cancer Stem-Cell Like Cells.
Yang S; Chen T; Huang L; Xu S; Cao Z; Zhang S; Xu J; Li Y; Yue Y; Lu W; Cheng X; Xie X
Cancer Manag Res; 2019; 11():9541-9552. PubMed ID: 31814758
[TBL] [Abstract][Full Text] [Related]
70. Nuclear lactate dehydrogenase A senses ROS to produce α-hydroxybutyrate for HPV-induced cervical tumor growth.
Liu Y; Guo JZ; Liu Y; Wang K; Ding W; Wang H; Liu X; Zhou S; Lu XC; Yang HB; Xu C; Gao W; Zhou L; Wang YP; Hu W; Wei Y; Huang C; Lei QY
Nat Commun; 2018 Oct; 9(1):4429. PubMed ID: 30356100
[TBL] [Abstract][Full Text] [Related]
71. Epitope Mapping and Computational Analysis of Anti-HPV16 E6 and E7 Antibodies in Single-Chain Format for Clinical Development as Antitumor Drugs.
Amici C; Donà MG; Chirullo B; Di Bonito P; Accardi L
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32640530
[TBL] [Abstract][Full Text] [Related]
72. Selection and characterization of a novel affibody peptide and its application in a two-site ELISA for the detection of cancer biomarker alpha-fetoprotein.
Liu J; Cui D; Jiang Y; Li Y; Liu Z; Tao L; Zhao Q; Diao A
Int J Biol Macromol; 2021 Jan; 166():884-892. PubMed ID: 33157139
[TBL] [Abstract][Full Text] [Related]
73. Targeting and retention of HPV16 E7 to the endoplasmic reticulum enhances immune tumour protection.
Loera-Arias MJ; Martínez-Pérez AG; Barrera-Hernández A; Ibarra-Obregón ER; González-Saldívar G; Martínez-Ortega JI; Rosas-Taraco A; Villanueva-Olivo A; Esparza-González SC; Villatoro-Hernandez J; Saucedo-Cárdenas O; Montes-de-Oca-Luna R
J Cell Mol Med; 2010 Apr; 14(4):890-4. PubMed ID: 19818090
[TBL] [Abstract][Full Text] [Related]
74. KSHV co-infection regulates HPV16+ cervical cancer cells pathogenesis
Dai L; Qiao J; Del Valle L; Qin Z
Am J Cancer Res; 2018; 8(4):708-714. PubMed ID: 29736315
[TBL] [Abstract][Full Text] [Related]
75. A Novel Bimodal Imaging Agent Targeting HER2 Molecule of Breast Cancer.
Lv W; Shen Y; Yang H; Yang R; Cai W; Zhang J; Yuan L; Duan Y; Zhang L
J Immunol Res; 2018; 2018():6202876. PubMed ID: 29854844
[TBL] [Abstract][Full Text] [Related]
76. The HPV16E7 Affibody as a Novel Potential Therapeutic Agent for Treating Cervical Cancer Is Likely Internalized through Dynamin and Caveolin-1 Dependent Endocytosis.
Zhang Q; Zhu H; Cui Z; Li Y; Zhuo J; Ye J; Zhang Z; Lian Z; Du Q; Zhao KN; Zhang L; Jiang P
Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009008
[TBL] [Abstract][Full Text] [Related]
77. Targeting HPV16 DNA using CRISPR/Cas inhibits anal cancer growth
Hsu DS; Kornepati AV; Glover W; Kennedy EM; Cullen BR
Future Virol; 2018 Jul; 13(7):475-482. PubMed ID: 30245733
[TBL] [Abstract][Full Text] [Related]
78. Supramolecular Nanofibers of Drug-Peptide Amphiphile and Affibody Suppress HER2+ Tumor Growth.
Liang C; Zhang L; Zhao W; Xu L; Chen Y; Long J; Wang F; Wang L; Yang Z
Adv Healthc Mater; 2018 Nov; 7(22):e1800899. PubMed ID: 30302950
[TBL] [Abstract][Full Text] [Related]
79. Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy.
Tolmachev V; Orlova A; Nilsson FY; Feldwisch J; Wennborg A; Abrahmsén L
Expert Opin Biol Ther; 2007 Apr; 7(4):555-68. PubMed ID: 17373906
[TBL] [Abstract][Full Text] [Related]
80. HPV16 E7 increases COX-2 expression and promotes the proliferation of breast cancer.
Wang YX; Zhang ZY; Wang JQ; Qian XL; Cui J
Oncol Lett; 2018 Jul; 16(1):317-325. PubMed ID: 29928417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
